Schedule 13D ownership disclosure

Kymera Therapeutics Inc

Security class unavailable · CUSIP: 501575104

Event date: 2024-08-21

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
6,001,262
Percent of class
9.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-091998
Form type
SC 13D/A
Filer
BAKER BROS. ADVISORS LP
CIK
CIK 1263508
Filed
Aug 22, 2024
Reporting period
Aug 21, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub